I had to scratch an awful lot of my stuff because a lot of the people around the table have asked some of the great questions I wanted to ask—albeit probably provided to me by Mr. Gerretsen, who is the king of great questions.
Mr. Bossio was talking about the risk-based approach. Julie, you note in your report:
The department's reactive approach to addressing reported product safety incidents did not provide an acceptable substitute for a more strategic assessment of risk to determine whether further attention to this issue may be warranted.
If Health Canada were to move away from a risk-based approach in favour of something more strategic, what would that look like? What would you suggest? What do you think might be a better approach?
We've talked a lot about the risk-based approach. We talked about it in our CEPA review. It has come up numerous times. Some people felt it worked pretty well. I'm not certain. I would be interested in your comments on that.